ATE328897T1 - Verwendung von hev-polypeptiden - Google Patents
Verwendung von hev-polypeptidenInfo
- Publication number
- ATE328897T1 ATE328897T1 AT01924610T AT01924610T ATE328897T1 AT E328897 T1 ATE328897 T1 AT E328897T1 AT 01924610 T AT01924610 T AT 01924610T AT 01924610 T AT01924610 T AT 01924610T AT E328897 T1 ATE328897 T1 AT E328897T1
- Authority
- AT
- Austria
- Prior art keywords
- polypeptides
- hev
- present
- pathogenesis
- vaccine
- Prior art date
Links
- 229920001184 polypeptide Polymers 0.000 title abstract 6
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 6
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 6
- 101710132601 Capsid protein Proteins 0.000 abstract 1
- 241000724675 Hepatitis E virus Species 0.000 abstract 1
- 101710169459 Secreted protein ORF2 Proteins 0.000 abstract 1
- 125000000539 amino acid group Chemical group 0.000 abstract 1
- 150000001413 amino acids Chemical group 0.000 abstract 1
- 230000000890 antigenic effect Effects 0.000 abstract 1
- 210000004899 c-terminal region Anatomy 0.000 abstract 1
- 239000003153 chemical reaction reagent Substances 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000004802 monitoring treatment efficacy Methods 0.000 abstract 1
- 230000003472 neutralizing effect Effects 0.000 abstract 1
- 230000008506 pathogenesis Effects 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/28011—Hepeviridae
- C12N2770/28111—Hepevirus, e.g. hepatitis E virus
- C12N2770/28122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Virology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US19538000P | 2000-04-07 | 2000-04-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE328897T1 true ATE328897T1 (de) | 2006-06-15 |
Family
ID=22721197
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01924610T ATE328897T1 (de) | 2000-04-07 | 2001-04-03 | Verwendung von hev-polypeptiden |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP1274725B1 (de) |
| AT (1) | ATE328897T1 (de) |
| AU (2) | AU5125001A (de) |
| CA (1) | CA2405084C (de) |
| DE (1) | DE60120391T2 (de) |
| WO (1) | WO2001077156A2 (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7786264B2 (en) * | 2001-11-08 | 2010-08-31 | Beijing Wantai Biological Pharmacy Enterprise Co., Ltd | Monoclonal antibody against hepatitis E virus or its fragment with binding activity and use thereof |
| US8112798B2 (en) | 2005-11-09 | 2012-02-07 | Microsoft Corporation | Hardware-aided software code measurement |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5736315A (en) * | 1992-10-21 | 1998-04-07 | National Institute Of Health | Methods and compositions for detecting anti-hepatitis E virus activity |
| ATE364631T1 (de) * | 1999-12-01 | 2007-07-15 | Us Gov Health & Human Serv | Hauptneutralisationsort des hepatitis e virus und verwendung dieses neutralisationsort in impfungverfahren und in verfahren zum screening nach neutralisationsantikörper |
-
2001
- 2001-04-03 DE DE60120391T patent/DE60120391T2/de not_active Expired - Lifetime
- 2001-04-03 WO PCT/US2001/010696 patent/WO2001077156A2/en active IP Right Grant
- 2001-04-03 AU AU5125001A patent/AU5125001A/xx active Pending
- 2001-04-03 AU AU2001251250A patent/AU2001251250B2/en not_active Ceased
- 2001-04-03 EP EP01924610A patent/EP1274725B1/de not_active Expired - Lifetime
- 2001-04-03 CA CA2405084A patent/CA2405084C/en not_active Expired - Fee Related
- 2001-04-03 AT AT01924610T patent/ATE328897T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| AU2001251250B2 (en) | 2006-01-19 |
| DE60120391D1 (de) | 2006-07-20 |
| WO2001077156A2 (en) | 2001-10-18 |
| CA2405084C (en) | 2011-06-14 |
| EP1274725B1 (de) | 2006-06-07 |
| EP1274725A2 (de) | 2003-01-15 |
| AU5125001A (en) | 2001-10-23 |
| DE60120391T2 (de) | 2007-06-06 |
| CA2405084A1 (en) | 2001-10-18 |
| WO2001077156A3 (en) | 2002-05-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE135747T1 (de) | Für das t-zell oberflächenprotein t4 kodierende dna und verwendung von t4-fragmenten bei der behandlung von aids | |
| EE200200709A (et) | Liitvalku sisaldava kompositsiooni ning seda liitvalku ja liitpolüpeptiidi kodeeriva nukleiinhappe kasutamine | |
| NO933126D0 (no) | Loeselige ligander for cd40 | |
| DE69637914D1 (de) | Impstoff gegen den für atemwegs- und reproduktionserkrankungen beim schwein verantwortlichen virus | |
| CY1107578T1 (el) | Πεπτιδια που χρησιμευουν στη θepαπεια ογκων και αλλων καταστασεων που χρηζουν την αφαιρεση ή την καταστροφη κυτταρων | |
| DE69934967D1 (de) | Verfahren zur verminderung der immunogenität von proteinen | |
| ATE371373T1 (de) | Durch polynukleinsäuren vom reproduktiven und respiratorischen syndromvirus des schweines kodierte proteine | |
| NO960309L (no) | Agonister og antagonister for humaninterleukin-10 | |
| SG144692A1 (en) | Antigenic proteins of shrimp white spot syndrome virus and uses thereof | |
| ATE349533T1 (de) | Zusammensetzung zur diagnose und behandlung von herpes simplex virusinfektionen | |
| ATE185148T1 (de) | Lipopeptide, t-cytotoxische lymphocyte aktivierend, und deren verwendung als vakzine | |
| ATE251886T1 (de) | Verwendunf von apoe zum binden von tau und map2c proteinen und zur behandlung von alzheimer's krankheit | |
| ATE432287T1 (de) | Peptidfragmente mit den zelltod verhindernder aktivität | |
| EP0236977A3 (de) | Impfstoffe gegen Rindervirus-Diarrhoe und Schweine-Cholera | |
| ATE103294T1 (de) | Peptidfragmente von hiv. | |
| DE60120391D1 (de) | Verwendung von hev-polypeptiden | |
| ATE448793T1 (de) | Rekombinante hybrid-allergenkonstrukte mit verringerter allergenität unter beibehaltung der immunogenität des natürlichen allergens | |
| ATE283281T1 (de) | T-zell epitope des raygraspollen-allergens | |
| DE60029327D1 (de) | Nukleinsaüre- und aminosaürensequenzen von infectious salmon anaemia virus, und deren verwendung als impfstoffe | |
| WO1998023752A3 (de) | Papillomviren, mittel zu deren nachweis sowie zur therapie von durch sie verursachten erkrankungen | |
| HUP0104254A2 (hu) | Ezrin szabályozó/kihajtogató peptidek | |
| HU906421D0 (en) | Process for testing analogous peptides of hiv | |
| DK204588A (da) | Humane rhinoviruspeptider, fremgangsmaade til deres fremstilling samt vacciner med inhold af saadanne peptider | |
| DE69012989D1 (de) | Peptiden von retinblastoma gen produkten und antikoerper dagegen. | |
| ATE530651T1 (de) | Leishmania antigene für verwendung in der therapie und diagnose von leishmaniose |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |